当前位置:首页 - 行情中心 - 西藏药业(600211) - 财务分析

西藏药业

(600211)

  

流通市值:119.35亿  总市值:119.35亿
流通股本:3.22亿   总股本:3.22亿

西藏药业(600211)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润2.83亿元,每股收益0.93元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益422775.28万元,未分配利润280009.63万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产639181.30万元,负债216406.01万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入723,548,218.032,981,538,230.432,089,270,909.971,650,705,155.36
营业总成本502,684,914.581,988,734,371.461,324,837,999.81,032,761,299.84
其他经营收益
营业利润316,296,922.741,043,831,968.47811,884,831.52638,690,965.16
利润总额316,636,987.521,040,617,869.2810,453,885.42637,320,433.54
净利润282,833,468.95916,980,955.72725,906,851.38570,788,875.89
每股收益
其他综合收益-12,073,799.08-17,441,769.97-13,885,663.2-4,937,939.25
综合收益总额270,759,669.87899,539,185.75712,021,188.18565,850,936.64
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计4,795,724,455.114,637,316,550.094,145,524,169.564,221,930,832.02
非流动资产:
非流动资产合计1,596,088,521.791,630,070,617.821,670,802,345.811,441,233,924.08
资产总计6,391,812,976.96,267,387,167.915,816,326,515.375,663,164,756.1
流动负债:
流动负债合计1,662,701,716.891,640,125,995.341,372,670,180.731,437,211,036.53
非流动负债:
非流动负债合计501,358,427.21489,779,958.59502,898,730.6628,305,877.44
负债合计2,164,060,144.12,129,905,953.931,875,568,911.391,465,516,913.97
所有者权益(或股东权益):
归属于母公司股东权益合计3,899,996,548.043,798,429,273.33,551,437,102.214,161,105,707.94
股东权益合计4,227,752,832.84,137,481,213.983,940,757,603.984,197,647,842.13
负债和股东权益合计6,391,812,976.96,267,387,167.915,816,326,515.375,663,164,756.1
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计1,140,989,052.393,280,245,803.152,577,290,963.791,694,938,622.22
经营活动现金流出小计757,538,069.722,275,494,997.231,864,226,050.891,094,723,350.6
经营活动产生的现金流量净额383,450,982.671,004,750,805.92713,064,912.9600,215,271.62
投资活动产生的现金流量:
投资活动现金流入小计1,326,273,251.134,554,882,655.33,330,412,806.082,301,977,179.02
投资活动现金流出小计1,699,053,183.65,143,957,010.343,930,974,808.092,700,270,233.9
投资活动产生的现金流量净额-372,779,932.47-589,074,355.04-600,562,002.01-398,293,054.88
筹资活动产生的现金流量:
筹资活动现金流入小计327,121,130.211,009,797,193.37816,728,712.81596,260,372.15
筹资活动现金流出小计229,185,029.341,132,420,354.43778,461,969.8493,570,713.64
筹资活动产生的现金流量净额97,936,100.87-122,623,161.0638,266,743.01102,689,658.51
汇率变动对现金及现金等价物的影响-21,090,592.86-22,454,136.39-1,319,965.01-4,034,954.9
现金及现金等价物净增加额87,516,558.21270,599,153.43149,449,688.89300,576,920.35
期末现金及现金等价物余额1,664,016,877.691,576,500,319.481,455,350,854.941,606,478,086.4
补充资料:
现金及现金等价物的净增加额-270,599,153.43-300,576,920.35
最新报告期:2026-04-11
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
华鑫证券吴景欢,胡博新3.073.273.532026-04-11
TOP↑